
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
Click the title above to open the Pharmaceutical Executive February 2019 issue in an interactive PDF format.
over 7 years ago
Q&A: Regulatory Reform in Chinaalmost 8 years ago
China: A Change in Attitudealmost 8 years ago
New Roads to Chinaalmost 8 years ago
Closing the Pharma and Digital Health Dividealmost 8 years ago
A Leading Man’s Next Actalmost 8 years ago
Two Steps Forwardalmost 8 years ago
Let the Drug Pricing Games Beginalmost 8 years ago
Mixed Outlook for China Life Sciencesalmost 8 years ago
CFIUS Reform’s Impact on Biopharmaalmost 8 years ago
Op-Ed: Opening the Golden Door




